Skip to main content

Serious Infection Risk from the Filgotinib Drug Development Program: Dr. James Galloway

Jun 17, 2021 10:47 am

Dr. Paul Studenic talks with Dr. James Galloway about abstract OP0126 presented at the virtual EULAR 2021 meeting.

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×